Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome.
REDWOOD CITY, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.91 | 3.95281456954 | 48.32 | 51.49 | 45.94 | 393747 | 48.39411786 | CS |
| 4 | 4.86 | 10.711924179 | 45.37 | 51.49 | 41.5 | 453051 | 46.60769114 | CS |
| 12 | -6.17 | -10.9397163121 | 56.4 | 60.92 | 41.5 | 593232 | 49.56129244 | CS |
| 26 | 3.22 | 6.84960646671 | 47.01 | 60.92 | 41.5 | 592896 | 50.32074592 | CS |
| 52 | 3.67 | 7.8823024055 | 46.56 | 60.92 | 36.61 | 507059 | 47.61095302 | CS |
| 156 | 49.88 | 14251.4285714 | 0.35 | 60.92 | 0.1302 | 723074 | 16.22655782 | CS |
| 260 | 47.02 | 1464.79750779 | 3.21 | 60.92 | 0.1302 | 801703 | 9.40609733 | CS |
| Symbol | Preis | Vol. |
|---|---|---|
| TCTMTCTM Kids IT Education Inc | US$ 0,764 (321,87%) | 729,72M |
| NVDANVIDIA Corporation | US$ 120,07 (-3,67%) | 388,54M |
| RIMEAlgorhythm Holdings Inc | US$ 0,02565 (5,12%) | 338,75M |
| BHATBlue Hat Interactive Entertainment Technology | US$ 0,0355 (-11,25%) | 236,29M |
| CLEUChina Liberal Education Holdings Ltd | US$ 0,1938 (30,77%) | 234,8M |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
